News & Updates

Adding pyrazinamide (PZA) to the initial tuberculosis (TB) treatment in older patients may lead to an increase in the incidence of adverse events (AEs), particularly allergic reactions, but not in-hospital mortality, length of hospital stay, or hepatotoxicity, reports a study, which used data from the Japanese Diagnosis Procedure Combination inpatient database.

Treatment with cytisine shows comparable efficacy to that of nortriptyline for smoking cessation at 1 year, according to a study. In addition, adverse events for both medications are few and well-tolerated.